Login / Signup

Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?

Alex ZhavoronkovQuentin VanhaelenTudor I Oprea
Published in: Clinical pharmacology and therapeutics (2020)
As the field of artificial intelligence and machine learning (AI/ML) for drug discovery is rapidly advancing, we address the question "What is the impact of recent AI/ML trends in the area of Clinical Pharmacology?" We address difficulties and AI/ML developments for target identification, their use in generative chemistry for small molecule drug discovery, and the potential role of AI/ML in clinical trial outcome evaluation. We briefly discuss current trends in the use of AI/ML in health care and the impact of AI/ML context of the daily practice of clinical pharmacologists.
Keyphrases
  • artificial intelligence
  • drug discovery
  • machine learning
  • big data
  • deep learning
  • healthcare
  • small molecule
  • clinical trial
  • primary care
  • randomized controlled trial
  • phase ii
  • quality improvement
  • protein protein